Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Aug 2026 for Jazz Pharmaceuticals plc.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Laura Hamill: trading record in brief
Laura Hamill is a declared insider at 4 companies (board member); the most frequent names are Y-mAbs Therapeutics, Inc., Jazz Pharmaceuticals plc and Gilead Sciences, Inc. The record holds 10 filings, for trades running from 8 May 2019 to 5 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 7 August 2026, reports a share grant in Jazz Pharmaceuticals plc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Laura Hamill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,605 shares0Ordinary SharesSEC:0001751804-26-000002:0
5,825 shares@ US$8.60100.0% of flowCommon StockSEC:0001751804-25-000004:0
3,507 shares0Ordinary SharesSEC:0001765581-25-000090:0
25,080 shares0Common StockSEC:0001415889-25-019050:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000066:0
3,495 shares0Common StockSEC:0001104659-24-071402:0
2,330 shares0Common StockSEC:0001104659-23-070046:0
474 sharesCommon StockSEC:0001104659-21-142273:0
9,840 shares0Common StockSEC:0001127602-19-018210:0
3,500 shares@ US$66.07Common StockSEC:0001127602-19-018210:1
10 of 10 declarations
